Adial Pharmaceuticals CEO to Participate in a Fireside Chat at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th Mar 22, 2022 09:15AM
Adial Pharmaceuticals Announces Closing of $10 Million Financing Feb 16, 2022 09:26AM
Adial Pharmaceuticals (ADIL) Prices 4.19M Share and Warrant Direct Offering at $2.40/sh Feb 11, 2022 09:01AM
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering Feb 11, 2022 09:00AM
Adial CEO William Stilley Invited to Participate in Maxim Group’s Virtual Panel Series Conference: “Disruptors in the Mental Health Space” Sep 15, 2021 10:07AM


Feb 26, 2019 08:00AM Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters’ Over-Allotment Option
Feb 21, 2019 08:45AM Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering